Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK
May Yung Tiet, Nazar AlShaikh
Abstract
Originating from Wuhan, China, COVID-19 has rapidly spread worldwide. Neurological manifestations are more commonly associated with severe COVID-19 infection. Guillain-Barré syndrome (GBS) is a rare immune-mediated postinfectious neuropathy. It has been reported as a possible rare complication of COVID-19. We report a case of GBS associated with COVID-19 in the UK.
Topics & Concepts
Guillain-Barre syndromeCoronavirus disease 2019 (COVID-19)MedicineComplicationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyPediatricsPathologyOutbreakDiseaseInternal medicineInfectious disease (medical specialty)Long-Term Effects of COVID-19Peripheral Neuropathies and DisordersPain Mechanisms and Treatments